Prolastin Articles
Isis Pharma and Ciba begin antisense cancer drug trial
29 January 1996
Prix Galien For Roche And Glaxo Wellcome
29 January 1996
Interferon Patent
22 January 1996
SciClone to repurchase common stock
8 January 1996
Bayer's Precose
8 January 1996
EU CPMP December Plenary Meeting
8 January 1996
ICN's Virazole Potential In Hep C
8 January 1996
P&U's Latanoprost Gets Go-Ahead
18 December 1995
Celgene: Synovir news
4 December 1995
Kassebaum "Threat To Orphan Drug R&D"
4 December 1995
Amaryl Approved In USA; 1st Launch In Sweden
4 December 1995
Treatment Of Chronic Hepatitis: New Options
4 December 1995
Transcend Appointment
20 November 1995
Glaxo Wellcome Unveils Revamped Pipeline
20 November 1995
Glaxo Wellcome Revamps R&D To Treble Productivity
13 November 1995
Pfizer Presents Fertile Pipeline
6 November 1995
Genentech And Roche Strengthen Relationship
6 November 1995
Mirtazepine Nears US Approval; 1st Alpha2 Blocker Antidepressant
30 October 1995
Hoffman-La Roche's Roferon-A Cleared
30 October 1995
US Drug Cos Reveal Strong Growth In 1995 3rd Qtr
30 October 1995
Yamanouchi Looks To New Products For Growth
23 October 1995
Revolution In Diabetes Type II Treatment Forecast
23 October 1995
Vertex Licenses Out Sickle Cell Treatment
16 October 1995
Ligand Retinoids Launch Double Assault On Kaposi's Sarcoma
16 October 1995
Japan's Fujisawa Looks To 21 Century Growth
16 October 1995
SmithKline Beecham Unveils Power Pipeline
9 October 1995
First Approval For Sankyo's Troglitazone
9 October 1995
Lilly Submits Olanzapine For Approval Worldwide
2 October 1995
US Govt Starts CenTNF Plus IL-2 Study In HIV-1
2 October 1995
Corporate News In Brief
25 September 1995
ICN Pharma/Schering-P begin collaboration
18 September 1995
Yamanouchi Launches Omnic In Holland
18 September 1995
Bayer's Acarbose Approved In USA
18 September 1995
Bayer launches Glucor
11 September 1995
Proscar Versus Hytrin And Cardura For BPH
11 September 1995
Alpha-Beta IND for Betafectin
4 September 1995
JAMA Study Ups Debate Over Calcium Blockers
4 September 1995
Roche Ahead Of Forecasts in 1995 First Half
4 September 1995
Results US Biopharmaceutical Firms Progress In Second Quarter
4 September 1995
Celgene Designs New Series Of Anti-Inflammatories
4 September 1995
Human milk antitumor agent
21 August 1995
Fujisawa's cloidine hydrochloride
21 August 1995
Bristol-Myers Squibb Forges New Tech Deals
21 August 1995
Athena: new Zanaflex results
7 August 1995
Intron A Gets Backing For Malignant Melanoma
7 August 1995
US Economic Slowdown Affects Larger Firms
7 August 1995
Recordati Sales Boost From Rx Abroad, Italian OTCs
7 August 1995
NEW YORK STOCK COMMENT
24 July 1995
Glaxo Wellcome Files First Dossier For 3TC
10 July 1995
New Targets For Autoimmune Disease?
10 July 1995
Merck pipline report
3 July 1995
Biotech Stocks Up, But Underperforming
3 July 1995
Schering-Plough Is "Right-Sized And Flexible"
3 July 1995
Bayer Broadens Research Efforts: Part Two
26 June 1995
Alpha-Beta results
19 June 1995
Interferon Sciences Targets MS
19 June 1995
Alpha Beta get broad patent for Betafactin
19 June 1995
Bayer's First Pipeline Presentation: Part 1
19 June 1995
Bayer's Acarbose Gains US Panel Backing
12 June 1995
Doxazosin Of Use In Diabetics, Says Study
12 June 1995
China: Biotech Drug Market Set To Boom
12 June 1995
Gensia Launches Arbutamine In UK
12 June 1995
Ligand/Allergan Start ALRT1057 Trials
12 June 1995
Phase III Betafectin Results By 4th Qtr?
12 June 1995
Biomira Sharpens Cancer Management Focus
12 June 1995
Wellferon Increases Survival In CML
5 June 1995
Zeria Pharmaceuticals launches Hanp Injection
29 May 1995
The ABPI's A-Z Of British Medicines Research
29 May 1995
Synaptic Wins BPH Drug Patent
15 May 1995
Biochem Pharma To File NDA For 3TC In June
15 May 1995
Interferon Approval In Mexico
24 April 1995
New HIV Vaccine Tested In USA
24 April 1995
Ciba Reveals Pipeline With Broad Reach
17 April 1995
Recordati Earnings Increase As Sales Decline
10 April 1995
Phase III Results For SciClone
3 April 1995
Reaferon Launch In Japan
3 April 1995
Mexico Approves Interferon's Altemol
3 April 1995
Oncolym Begins Phase II/III trials
27 March 1995
W-L And BASF Form ICE Inhibitor Collaboration
27 March 1995
Prospects In Genetic-Based Cancer Therapies
27 March 1995
Pharmacia Pipeline Promises Future Growth
20 March 1995
Sumitomo Pharma Profits Down Sharply
20 March 1995
Betafectin Trial
6 March 1995
Controversy Over New French Drug Policy
27 February 1995
Interferon Agreement
13 February 1995
Pfizer's Cardura Approved For BPH
13 February 1995
New Chemical Entities Round-Up For 1994
6 February 1995
End Of Year Encouraging For US Companies
6 February 1995
US Firms seek Ban On HIV Class action
6 February 1995
Novo Nordisk Backs Scottish Biotech Firm
6 February 1995
Roche's Sales Ahead, Profit Growth Expected
23 January 1995
UK Approval For Efexor; Comparative Data
16 January 1995
Mixed Six Month Results From Japan's Drugmakers
9 January 1995
Highlights Of SmithKline's R&D Portfolio
2 January 1995
Biogen Comes Back Into Europe
19 December 1994
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
